Committee opinion no. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy

Obstetrics and Gynecology

Volumn 108, Issue 6, 2006, Pages 1601-1603

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL ABUSE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CRYING; DEPRESSION; DRUG CONTRAINDICATION; DRUG USE; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MEDICAL PRACTICE; MEDICAL SOCIETY; MUSCLE TONE; NERVOUSNESS; NEWBORN DISEASE; NEWBORN PERSISTENT PULMONARY HYPERTENSION; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGISTER; RELAPSE; RESPIRATORY DISTRESS; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; SIDE EFFECT; SUBSTANCE ABUSE; TACHYPNEA; TRANSIENT TACHYPNEA OF THE NEWBORN; TREATMENT PLANNING; WEAK CRY; WEIGHT GAIN; ARTICLE; PREGNANCY COMPLICATION;

DEPRESSION; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS;

EID: 33845396736     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-200612000-00058     Document Type: Short Survey

References (16)

1. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85-96.
2. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005;106:1071-83.
3. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment [published erratum appears in JAMA 2006;296:170]. JAMA 2006;295:499-507.
4. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005;293:2372-83.
5. Wisner KL, Zarin DA, Holmboe ES, Appelbaum PS, Gelenberg AJ, Leonard HL, et al. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 2000;157:1933-40.
6. Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 2006;194:961-6.
7. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005;106:1289-96.
8. Lamberg L. Risks and benefits key to psychotropic use during pregnancy and postpartum period. JAMA 2005;294:1604-8.
9. Reefhuis J, Rasmussen SA, Friedman JM. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn [letter]. N Eng J Med 2006;354:2188-9.
10. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 2005;14:823-7.
11. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Eng J Med 1996;335:1010-15.
12. Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32.
13. Kallen B. Neonate characteristics after maternal use of antidepressants late in pregnancy. Arch Pediatr Adolesc Med 2004;158:312-6.
14. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004;113:368-75.
15. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Eng J Med 2006;354:579-87.
16. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006;160:173-6.